Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2014-11-30
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We hypothesize that interactive VME will lead to non-inferior rates of ability to demonstrate correct inhaler use compared to rates with TTG among hospitalized patients with Asthma or COPD.
For this study we are testing the preliminary efficacy of VME to teach respiratory inhaler technique prior to implementing a larger RCT to test the comparative effectiveness of VME versus TTG.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Educational Intervention in Patients With Low-Risk Chronic Obstructive Pulmonary Disease
NCT00932711
At Home Spirometry and Video Module Education for COPD Patients
NCT03834350
Education With Inhalers in Patients With COPD Exacerbation
NCT03337958
Inhaler Trainer Efficacy Study
NCT06461403
Effectiveness and Cost Impact of a Telecommunications System in COPD
NCT00012805
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To iteratively test VME to teach correct use of metered dose inhaler (MDIs) and dry-powder DiskusĀ® devices to hospitalized patients with Asthma or COPD. We partnered with software development companies to develop VME modules that (self)-assess and teach respiratory inhaler technique to hospitalized participants. We have tested the VME in focus groups. Now that the VME is developed we will iteratively pilot test (n=30-40) the VME strategy (up to 3 rounds (90-120 total)) to obtain important patient feedback,preferences and preliminary efficacy estimates for the module.
We hypothesize that participants' post-VME inhaler technique will be significantly better than their pre-VME inhaler technique.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VME Group
Pre and post VME education group. The Intervention is the use of the virtual education module rather than the interpersonal educational strategy.
VME Group
Received inhaler education through VME (virtual education module)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VME Group
Received inhaler education through VME (virtual education module)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Admission to the inpatient medical service and surgical service
3. Physician-diagnosed COPD or asthma. We will enroll patients even if the primary reason for admission is not COPD or asthma (e.g., patients admitted for heart failure, but with a physician diagnosis of COPD are eligible).
Exclusion Criteria
2. Physician declines to provide consent
3. Patient unable to provide consent (e.g., history of cognitive impairment, unable to understand English) or declines to provide consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valerie G. Press, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB12-1844
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.